Literature DB >> 20698461

Effect of combined administration of transforming growth factor-b1 and insulin-like growth factor I on the mechanical properties of a patellar tendon defect model in rabbits.

Dimitrios N Lyras1, Konstantinos Kazakos, Dionysios Verettas, Efstathios Chronopoulos, Semiu Folaranmi, George Agrogiannis.   

Abstract

The aim of this study was to test the hypothesis that combined administration of TGF-b1 and IGF-I in a patellar tendon defect model could enhance the mechanical properties of the healed tendon. Twenty four New Zealand white rabbits were used for this purpose. In each animal, the right knee was used for the application of the growth factors, whereas the left knee served as an untreated control. The growth factors were mixed with fibrin sealant as a delivery vehicle. Two groups of rabbits were sacrificed after 2 weeks and 6 weeks respectively. Application of the growth factors resulted in a significant increase in force at failure, ultimate stress, stiffness, and energy uptake at 2 weeks, whereas none of the parameters revealed any significant difference between the two groups at 6 weeks. This study provides valuable information on the effect of the two growth factors on this patellar tendon defect model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698461

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  12 in total

Review 1.  Augmenting tendon and ligament repair with platelet-rich plasma (PRP).

Authors:  Ting Yuan; Chang-Qing Zhang; James H-C Wang
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

Review 2.  Regeneration of the anterior cruciate ligament: Current strategies in tissue engineering.

Authors:  Thomas Nau; Andreas Teuschl
Journal:  World J Orthop       Date:  2015-01-18

Review 3.  What we should know before using tissue engineering techniques to repair injured tendons: a developmental biology perspective.

Authors:  Chia-Feng Liu; Lindsey Aschbacher-Smith; Nicolas J Barthelery; Nathaniel Dyment; David Butler; Christopher Wylie
Journal:  Tissue Eng Part B Rev       Date:  2011-03-21       Impact factor: 6.389

4.  Growth Factor Roles in Soft Tissue Physiology and Pathophysiology.

Authors:  Jennifer H Roberts; Jaroslava Halper
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial.

Authors:  Roberto Seijas; Marta Rius; Oscar Ares; Montserrat García-Balletbó; Iván Serra; Ramón Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-27       Impact factor: 4.342

6.  Partial anterior cruciate ligament tears treated with intraligamentary plasma rich in growth factors.

Authors:  Roberto Seijas; Oscar Ares; Xavier Cuscó; Pedro Alvarez; Gilbert Steinbacher; Ramón Cugat
Journal:  World J Orthop       Date:  2014-07-18

Review 7.  Biomaterials for the Treatment of Tendon Injury.

Authors:  Sung Eun Kim; Jae Gyoon Kim; Kyeongsoon Park
Journal:  Tissue Eng Regen Med       Date:  2019-09-13       Impact factor: 4.169

8.  Calcium alginate gels as stem cell matrix-making paracrine stem cell activity available for enhanced healing after surgery.

Authors:  Andreas Schmitt; Philipp Rödel; Cihad Anamur; Claudine Seeliger; Andreas B Imhoff; Elmar Herbst; Stephan Vogt; Martijn van Griensven; Gerhard Winter; Julia Engert
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  A Clinical, Biological, and Biomaterials Perspective into Tendon Injuries and Regeneration.

Authors:  Grace Walden; Xin Liao; Simon Donell; Mike J Raxworthy; Graham P Riley; Aram Saeed
Journal:  Tissue Eng Part B Rev       Date:  2016-09-30       Impact factor: 6.389

10.  Lactoferrin and parathyroid hormone are not harmful to primary tenocytes in vitro, but PDGF may be.

Authors:  David S Musson; Mei Lin Tay; Ashika Chhana; Bregina Pool; Brendan Coleman; Dorit Naot; Jillian Cornish
Journal:  Muscles Ligaments Tendons J       Date:  2017-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.